Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report

Zhisheng Liu,1,* Junling Zhang,2,* Yunjie Ge,3 Mengli Huang,2 Ye Wang1 1Department of General Surgery, Affiliated Qingdao Hiser Hospital of Qingdao University (Qingdao Hospital of Traditional Chinese Medicine), Qingdao, Shandong People’s Republic of China; 2Medical Department, 3D Med...

Full description

Bibliographic Details

Published in:	Cancer Management and Research
Main Authors:	Liu Z, Zhang J, Ge Y, Huang M, Wang Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-02-01
Subjects:	c-sclc lusc pd-1 inhibitor high tumor mutational burden
Online Access:	https://www.dovepress.com/rare-combined-small-cell-lung-carcinoma-and-lung-squamous-cell-carcino-peer-reviewed-fulltext-article-CMAR